News

LAPIX Therapeutics Inc. Announces First Subjects Dosed in its First-in-Human Clinical Study of its Treg-expanding Tim3/4 Agonist LPX-TI641 to Treat Multiple Sclerosis and other Autoimmune Conditions

BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable…

1 year ago

Glow Lifetech Announces New Product Listings from Ontario Cannabis Store; Expanding MOD Drops Portfolio and First Shipment of .decimal Capsules

Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the…

1 year ago

CBD of Denver Inc. Announces Significant Advancements in European Operations by Luxora Team

Denver, Colorado--(Newsfile Corp. - November 7, 2023) - Last week, the CBD of Denver, Inc.'s (OTC Pink: CBDD), Luxora team…

1 year ago

FendX to Conduct Second Pilot Run on Dunmore’s Commercial Manufacturing Line for Further Development of REPELWRAP(TM) Film

Oakville, Ontario--(Newsfile Corp. - November 7, 2023) - FendX Technologies Inc. (CSE:FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX")…

1 year ago

Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization

Scientist, inventor, business expert, and holder of more than 140 patents will bring forward PUR Biologics' regenerative therapeutic patent portfolio…

1 year ago

Nemysis Limited Receives EU Horizon Grant Funding for E40

DUBLIN, IRELAND / ACCESSWIRE / November 7, 2023 / Nemysis is pleased to announce receipt of grant funding under the…

1 year ago

Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) -  Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or…

1 year ago

Nomination Committee Appointed for IRLAB’s Annual General Meeting 2024

GOTHENBURG, SE / ACCESSWIRE / November 07, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, November 7, 2023 - IRLAB…

1 year ago

Hecla Reports Third Quarter 2023 Results

For The Period Ended: September 30, 2023COEUR D'ALENE, Idaho--(BUSINESS WIRE)--Hecla Mining Company (NYSE:HL) today announced third quarter 2023 operating and…

1 year ago